Search filters

List of works by Mary A Marovich

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells

scientific article published on 16 September 2011

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

scientific article

A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection

scientific article

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

scientific article

ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development

scientific article published in August 2004

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania ⬇️

scientific article published on August 22, 2011

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

scientific article published on November 2008

Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire

scientific article published on 24 November 2010

Central nervous system viral invasion and inflammation during acute HIV infection

scientific article

Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

scientific article published on 11 January 2016

Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research

scientific article published on 13 May 2015

Complement-mediated neutralization of dengue virus requires mannose-binding lectin

scientific article published on 13 December 2011

Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia

scientific article published on 13 May 2015

Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

scientific article published on 14 September 2017

Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.

scientific article

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

scientific article

Defining epitope coverage requirements for T cell-based HIV vaccines: Theoretical considerations and practical applications ⬇️

scientific article published on December 8, 2011

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines

scientific article published on 03 August 2009

Designing the epitope flanking regions for optimal generation of CTL epitopes.

scientific article published on 2 May 2014

Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection

scientific article published on 13 September 2017

Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors

scientific article published on 4 April 2007

Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

scientific article published on 20 December 2012

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

scientific article published on 30 December 2020

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

scientific article

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection

scientific article published on August 2009

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

scientific article published on 3 February 2016

HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients ⬇️

scientific article published on July 31, 2013

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens

scientific article

Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection

scientific article published on 24 April 2013

Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif

scientific article

Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations

scientific article

Identification of germinal center B cells in blood from HIV-infected drug-naive individuals in Central Africa

scientific article published on March 2004

Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.

scientific article

Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses

scientific article published in October 2012

Immunology. Immune activation with HIV vaccines

scientific article published on April 2014

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

scientific article

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation

scientific article

Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans

scientific article

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

scientific article

Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent

scientific article

Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans

article

Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment

scientific article

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

scientific article

Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults

scientific article

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

scientific article

Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen

scientific article

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

scientific article

Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

scientific article published on 3 May 2017

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial

scientific article

Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review ⬇️

scientific article published on January 17, 2013

Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses

scientific article

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

scientific article published on 31 July 2017

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

scientific article published on 29 May 2009

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

scientific article

Safety and Immunogenicity of PENNVAX®-G DNA Prime Administered by Biojector® 2000 or CELLECTRA® Electroporation Device with Modified Vaccinia Ankara-CMDR Boost

scientific article published on 2 September 2017

Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals

scientific article published on 16 March 2016

Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection

scientific article published in September 2012

Specific antibody production by blood B cells is retained in late stage drug-naïve HIV-infected Africans

scientific article published on June 2004

Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes

scientific article

The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy

scientific article published on 20 October 2015

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization ⬇️

scientific article published on April 11, 2012

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope ⬇️

scientific article published on April 23, 2012

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

scientific article published on 4 January 2012

Paulina is supported by:

About Paulina

Help